Osmessn.com

Image Credit: Adobe Stock Images/KevinRuck.com Key Takeaways To meet rising demand, Bora Pharmaceuticals is expanding its Baltimore facility by installing an automated vial, syringe, and cartridge line by 2026, enhancing its capabilities for small-scale, high-value drug production. The expansion supports increased demand for fill-finish services related to potent drugs and treatments for rare and orphan […]

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies […]

Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization A Pharmaceutical Executive article explores how specialty pharmacy programs can significantly improve outcomes for patients with rare diseases—like cystic fibrosis—by providing faster access to treatment, better medication adherence, and personalized support that addresses the complex challenges of managing lifelong conditions. Rethinking Clinical Trial […]

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the US population affected, the issue is increasingly urgent, particularly as major chains like Rite Aid […]

In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role in identifying and addressing pharmacy deserts—areas where access to pharmacies is limited or nonexistent. With an estimated 17.7% of the US population affected, the issue is increasingly urgent, particularly as major chains like Rite Aid […]

Image Credit: Adobe Stock Images/Wladimir1804.com Key Takeaways MA enrollment among full-benefit dual-eligible beneficiaries is rising, reaching nearly 50% by 2022. FIDE-SNP enrollees have greater health and support needs than those in other MA plan types. FIDE-SNP enrollees are more likely to live in less disadvantaged areas, pointing to access disparities. Enrollment in Medicare Advantage (MA) […]

GLP-1 Drugs may be Linked to Elevated Risk of Serious Eye Disease, Study Finds A new observational study finds that people with diabetes taking GLP-1 drugs have a low but doubled risk of developing neovascular age-related macular degeneration, an eye disease that can cause blindness, highlighting the need for increased awareness and monitoring of eye […]

Image Credit: Adobe Stock Images/Hugnaka.com Key Takeaways BioNTech and Bristol Myers Squibb have entered a major global collaboration to co-develop and co-commercialize BNT327, a bispecific antibody for solid tumors, with $1.5B upfront, $2 billion total in non-contingent anniversary payments through 2028, and up to $7.6B in milestone payments. BNT327 is already in global Phase III […]

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies […]

Image Credit: Adobe Stock Images/Somneuk.com Key Takeaways Tariffs could spike drug costs: Proposed 25% tariffs on pharmaceuticals may raise US drug prices by up to 12.9% and cost the industry an estimated $51 billion annually. Supply chain disruption is growing: Pharma and medtech sectors face significant supply chain strain, including delays and pricing spikes, due […]

Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them In a Pharmaceutical Executive feature, Gen Li, founder, CEO, Phesi, outlines five key challenges hindering investigator site selection in clinical trials—including unreliable performance predictions and lack of real-world data—and explains how clinical data science and AI-driven tools can optimize site […]

Key Takeaways Exceptional CX significantly boosts engagement with healthcare professionals and consumers, leading to increased prescriptions, better market penetration, and improved health outcomes. Pharma companies are leveraging AI-driven omnichannel platforms to unify customer data, personalize interactions, and meet rising expectations across direct-to-consumer and direct-to-patient models. Unified platforms powered by AI enable pharma companies to deliver […]

Preparing for the Pharma C-Suite In a Pharmaceutical Executive feature, Aileen Fernandes, Chief Business Officer at Arcellx, reflects on how her early roles at Morgan Stanley and Deloitte Consulting, combined with strategic career decisions and authentic leadership development, prepared her for biotechnology C-suite success and offers MBA students key advice on culture fit, building healthcare […]

In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption in supply chain-specific applications, as highlighted in Logility’s Supply Chain Horizons 2025 Market Report. He identified several key reasons for this disconnect. First, many companies […]

May 28th 2025 Article Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continuous -80°C temperature control and dry ice replenishment throughout an 80-hour transit – Marken activated a customized, precision-driven supply chain strategy. Navigating one of the world’s most complex regulatory landscapes for advanced therapies, […]

When Coretta learned she had stage 4 non-small cell lung cancer, she was blindsided. She didn’t fit the profile. She didn’t see it coming. And she didn’t know what to do next. It’s a common experience in serious diagnoses—patients feel not just fear but paralysis. The problem? Coretta had never faced a challenge like this […]

May 28th 2025 Article When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy under the strictest regulatory and temperature specifications. With precise temperature-control required at -80°C with dry ice, Marken’s teams navigated weekend scheduling, specialized package handling and final-mile complexities to ensure the vital treatment remained on schedule […]